Investors Research Corp’s ArcBest ARCB Stock Holding History

Investors Research Corp’s Portfolio ARCB Stock Details ARCB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,800	Closed	-$346K	–	339
2018 Q1	$346K	Hold	10,800	–	–	0.21%	193
2017 Q4	$386K	Buy	+10,800	New	+$368K	0.24%	158

Other funds holding ARCB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Investors Research Corp's ARCB Position: Q2 2018 in Review

Investors Research Corp sold out of ArcBest (ARCB) in Q2 2018, closing a stake of 10,800 shares — an estimated $346K sold.

Investors Research Corp first reported a position in ARCB in Q4 2017 and held it in 2 quarters. The position peaked at $386K in Q4 2017. 219 funds tracked by Wall St. Rank hold ARCB as of Q2 2018.

Investors Research Corp reported no remaining ArcBest position as of Q2 2018 after selling out during the quarter.
Investors Research Corp sold 10,800 ArcBest shares in Q2 2018, an estimated $346K.
Investors Research Corp first reported a position in ArcBest in Q4 2017 and held it in 2 quarters.
Investors Research Corp's ArcBest position peaked at $386K in Q4 2017.
219 funds tracked by Wall St. Rank held ArcBest as of Q2 2018.

Based on Investors Research Corp's 13F filing for Q2 2018, filed 10 Aug 2018.